These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26539558)

  • 1. Experimental Immunization Based on Plasmodium Antigens Isolated by Antibody Affinity.
    Kamali AN; Marín-García P; Azcárate IG; Puyet A; Diez A; Bautista JM
    J Immunol Res; 2015; 2015():723946. PubMed ID: 26539558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice.
    Kamali AN; Marín-García P; Azcárate IG; Diez A; Puyet A; Bautista JM
    Immunobiology; 2012 Aug; 217(8):823-30. PubMed ID: 22658767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.
    Hunter RL; Kidd MR; Olsen MR; Patterson PS; Lal AA
    J Immunol; 1995 Feb; 154(4):1762-9. PubMed ID: 7836760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection.
    Narum DL; Ogun SA; Thomas AW; Holder AA
    Infect Immun; 2000 May; 68(5):2899-906. PubMed ID: 10768987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens.
    Burns JM; Dunn PD; Russo DM
    Infect Immun; 1997 Aug; 65(8):3138-45. PubMed ID: 9234766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
    Rotman HL; Daly TM; Long CA
    Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
    Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
    Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice.
    Sharma SK; Gupta C; Dwivedi V; Misra-Bhattacharya S; Mohammad O
    Vaccine; 2007 Mar; 25(11):2103-11. PubMed ID: 17241709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
    Rotman HL; Daly TM; Clynes R; Long CA
    J Immunol; 1998 Aug; 161(4):1908-12. PubMed ID: 9712060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
    Wang L; Goschnick MW; Coppel RL
    Infect Immun; 2004 Oct; 72(10):6172-5. PubMed ID: 15385527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria ookinete surface protein-based vaccination via the intranasal route completely blocks parasite transmission in both passive and active vaccination regimens in a rodent model of malaria infection.
    Arakawa T; Tachibana M; Miyata T; Harakuni T; Kohama H; Matsumoto Y; Tsuji N; Hisaeda H; Stowers A; Torii M; Tsuboi T
    Infect Immun; 2009 Dec; 77(12):5496-500. PubMed ID: 19752035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to liver-stage parasites: implications for vaccine development.
    Hollingdale MR; Krzych U
    Chem Immunol; 2002; 80():97-124. PubMed ID: 12058653
    [No Abstract]   [Full Text] [Related]  

  • 13. A blood stage fraction of Plasmodium berghei induces protective and long lasting immune response in BALB/c mice.
    Bagai U; Pawar A
    Parasitol Int; 2013 Jun; 62(3):329-36. PubMed ID: 23085043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
    Burns JM; Flaherty PR; Nanavati P; Weidanz WP
    Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged expression of IFNgamma induced by protective blood-stage immunization against Plasmodium yoelii malaria.
    Patterson PS; Bosshardt SC; Udhayukumar V; Xiao L; Kidd M; Hunter RL; Lal AA
    Vaccine; 1999 Aug; 18(1-2):173-80. PubMed ID: 10501247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes.
    Tachibana M; Ishino T; Tsuboi T; Torii M
    Vaccine; 2018 Nov; 36(49):7463-7471. PubMed ID: 30420038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive immunization against murine malaria with an IgG3 monoclonal antibody.
    Majarian WR; Daly TM; Weidanz WP; Long CA
    J Immunol; 1984 Jun; 132(6):3131-7. PubMed ID: 6725950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
    Aly AS; Downie MJ; Mamoun CB; Kappe SH
    Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and identification of malaria vaccine target molecule using bioinformatics and DNA vaccination.
    Shuaibu MN; Kikuchi M; Cherif MS; Helegbe GK; Yanagi T; Hirayama K
    Vaccine; 2010 Oct; 28(42):6868-75. PubMed ID: 20709002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.